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Abstract: Individuals with end-stage diabetic peripheral neuropathy present with decreased pain
sensation. Transient receptor potential vanilloid type 1 (TRPV1) is implicated in pain signaling
and resides on sensory dorsal root ganglion (DRG) neurons. We investigated the expression
and functional activity of TRPV1 in DRG neurons of the Ins2+/Akita mouse at 9 months of
diabetes using immunohistochemistry, live single cell calcium imaging, and whole-cell patch-clamp
electrophysiology. 2′,7′-Dichlorodihydrofluorescein diacetate (DCFH-DA) fluorescence assay was
used to determine the level of Reactive Oxygen Species (ROS) in DRGs. Although TRPV1 expressing
neuron percentage was increased in Ins2+/Akita DRGs at 9 months of diabetes compared to control,
capsaicin-induced Ca2+ influx was smaller in isolated Ins2+/Akita DRG neurons, indicating impaired
TRPV1 function. Consistently, capsaicin-induced Ca2+ influx was decreased in control DRG neurons
cultured in the presence of 25 mM glucose for seven days versus those cultured with 5.5 mM glucose.
The high glucose environment increased cytoplasmic ROS accumulation in cultured DRG neurons.
Patch-clamp recordings revealed that capsaicin-activated currents decayed faster in isolated Ins2+/Akita
DRG neurons as compared to those in control neurons. We propose that in poorly controlled diabetes,
the accelerated rate of capsaicin-sensitive TRPV1 current decay in DRG neurons decreases overall
TRPV1 activity and contributes to peripheral neuropathy.
Keywords: calcium influx; DRG neurons; Ins2+/Akita mouse; ROS; capsaicin; TRPV1
1. Introduction
Individuals diagnosed with diabetes mellitus are at increased risk of developing
microcomplications of the disease, including diabetic retinopathy, renal failure, and peripheral
neuropathy. Peripheral neuropathy is one of the most common complications of end-stage diabetes,
which manifests as symmetrically decreased pain sensation in the lower extremities and is associated
with a high incidence of foot ulceration. A retrospective study in 2015 estimated the prevalence of
peripheral neuropathy to be about 30% in diabetic patients [1], while other studies have reported up
to 80% [2,3].
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Despite the high prevalence of this condition, the mechanisms underlying this dysfunction are
poorly understood, limiting the development of new therapeutic strategies. The peripheral processes
of dorsal root ganglion (DRG) neurons innervate the cutaneous surface of the foot. The transient
receptor potential vanilloid type 1 (TRPV1) channel is a Ca2+ permeable plasma membrane cation
channel that can be activated by heat, acid, and capsaicin [4–6] and is expressed robustly in the
nociceptive sensory neurons of DRG [7,8]. TRPV1 is known to be upregulated in a number of clinical
disease-associated pain conditions [9–12]. Animal models of induced diabetes have demonstrated
increased TRPV1 expression that correlates to hyperalgesia and decreased TRPV1 expression in
hypoalgesia [13], reflecting earlier and later manifestations of diabetic neuropathy, respectively.
Elevated Reactive Oxygen Species (ROS) are associated with the pathogenesis of diabetes and
diabetic complications [14]. Hyperglycemia is the major trigger of ROS accumulation in diabetes.
Notably, TRPV1 channels are sensitive to ROS. It has been demonstrated that H2O2 activates TRPV1 and
potentiates the capsaicin-induced TRPV1 currents after short-term treatment and that the prolonged
treatment with H2O2 reduced the capsaicin-induced TRPV1 current amplitude in human embryonic
kidney (HEK) cells [15,16]. ROS are known to be elevated in hereditary model of diabetes, such as
Ins2+/Akita mice, exhibiting hyperglycemia and hypoinsulinemia, but no obesity [17].
In this study, we investigated the function activity of TRPV1 in DRG neurons from long-term
diabetic Ins2+/Akita mice to determine whether TRPV1 activity is modulated under a diabetic
environment. We also assessed short-term changes in high glucose-induced ROS accumulation in
DRG neurons.
2. Results
2.1. Changes in Blood Glucose Level, Body Weight
Ins2+/Akita mouse is a hereditary model of diabetes [18–20]. In this study, only male wild-type
and Ins2+/Akita mice were used as the male Ins2+/Akita mice show more profound diabetic phenotype
than the female mice [19,20]. Mice were observed for a period of 36 weeks after the onset of
diabetes. Blood glucose levels were significantly elevated within 6 weeks and remained elevated
(520 ± 21.4 mg/dL, n = 4) as compared to control non-diabetic mice (216 ± 27.2 mg/dL, n = 4). As the
disease progressed (9 months after the onset of diabetes), the overall body weight of the Ins2+/Akita
mice (23.1 ± 1.8 g, n = 6) was much lower when compared to their wild-type littermates (40.7 ± 1.7 g,
n = 6).
2.2. Increased Positive TRPV1 Staining DRGs Neurons in Ins2+/Akita Mice
Studies using Ins2+/Akita mice reportedly exhibit impaired thermal nociception at an age of
12 weeks [21]. Channels thought to contribute to these changes include TRPV1, which is known to be
upregulated in several clinical disease-associated pain conditions [9–12]. Consistently, Figure 1A,B
shows that a greater number of neurons are TRPV1 positive in Ins2+/Akita DRGs (27.3 ± 1.83%, n = 7,
42 section slices from seven Ins2+/Akita mice) when compared with wild-type DRGs (18.0± 1.56%, n = 7,
42 section slices from seven wild-type mice).
2.3. Capsaicin-Evoked [Ca2+]i Responses in Wild-Type and Ins2+/Akita DRGs
Capsaicin, a member of the vanilloid family, binds to TRPV1 and depolarizes isolated
sensory neurons. In Figure 1C,D, we can see that the percentage of isolated DRG neurons
(cultured overnight after isolation) sensitive to capsaicin (100 nM) in the Ins2+/Akita group (42.7 ± 6.5%,
321 cells from six mice) was not different from the wild-type group (49.8 ± 7.2%, 337 cells from
five mice). However, the capsaicin-induced intracellular calcium increases in Ins2+/Akita neurons
(∆F340/F380*s = 0.26 ± 0.04, n = 6, 321 cells from six mice) were significantly smaller than those in
wild-type neurons (∆F340/F380*s = 0.43 ± 0.05, n = 5, 337 cells from five mice). The intracellular
calcium increases induced by 70 KCl was not different between the Ins2+/Akita and wild-type (right inset
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in Figure 1C). These data suggest that TRPV1 function may be impaired in diabetic Ins2+/Akita
DRG neurons.Molecules 2019, 24, x FOR PEER REVIEW 3 of 13 
 
 
Figure 1. Transient receptor potential vanilloid type 1 (TRPV1) channel expression and capsaicin-
evoked Ca2+ transients in dorsal root ganglion (DRG) neurons from wild-type and Ins2+/Akita mice at 9 
months of diabetes. (A) Sample images of immunohistochemistry showing the expression of TRPV1 
in DRG neurons of wild-type and Ins2+/Akita mice (Akita). Arrows indicate neurons with positive 
TRPV1 staining. (B) Percentage of TRPV1-positive neurons in wild-type and Ins2+/Akita (Akita) mice. 
The percentage of TRPV1-positive neurons was determined in six segments of each mouse DRG 
section and averaged. The dots represent the percentage determined for each wild-type or Ins2+/Akita 
mouse (n = seven mice for each condition; p = 0.0008). (C) Sample traces of time-course of capsaicin 
(Caps)-and 70 KCl-induced [Ca2+]i rises in DRG neurons isolated from one control or one Akita mouse. 
The experiments were repeated five to six times in DRG neurons isolated from additional five to six 
mice. Solid lines are averaged [Ca2+]i changes. The vertical lines represent SEM. The compounds were 
applied at the times indicated with the horizontal bars. The right inset shows the summary of 
fluorescence changes induced by 70 KCl. Each dot represents the averaged fluorescence change value 
determined during a fluorescence imaging experiment on a coverslip with 20 to 150 DRG neurons (n 
= 321–335 cells from five to six mice for each condition; p = 0.62). (D) The summary data of the average 
percentage of DRG neurons sensitive to capsaicin. Each dot represents the averaged percentage value 
determined in the tested cells from each mouse (n = five mice; p = 0.47). (E) Summary data of the areas 
under the response curves for C. Each dot represents the averaged area values determined for the 
tested cells on each coverslip. There were 20 to 150 isolated DRG neurons per coverslip from one 
mouse assessed in each experiment. Five wild-type and six Ins2+/Akita mice were used for these 
experiments. Only the neurons exhibiting Ca2+ increases in the presence of 70 KCl were included in 
the statistics. The t test was used to determine whether there was a significant difference between the 
tested groups (p = 0.027). * indicates p < 0.05 and *** indicates p < 0.001. 
2.4. Voltage-Gated Calcium and TRPV1 Currents in Wild-Type and Ins2+/Akita DRG Neurons 
Ion channels, such as voltage-gated potassium channels, are known to be altered in neurons 
derived from diabetic rodents [22]. To determine the degree to which voltage-gated Ca2+ channels 
were affected by a diabetic environment, we measured voltage-gated Ca2+ currents in small-and mid-
sized Ins2+/Akita and wild-type DRG neurons. The cells were cultured overnight before the whole cell 
patch-clamp experiments. We found that the voltage-gated Ca2+ current amplitudes were not 
different in Ins2+/Akita (−157.9 ± 23.4 pA/pF, n = 15) and wild-type (−147.7 ± 21.1 pA/pF, n = 15, Figure 
Figure 1. Transient receptor potential vanilloid type 1 (TRPV1) channel expression and
capsaicin-evoked Ca2+ transients in dorsal root ganglion (DRG) neurons from wild-type and Ins2+/Akita
mice at 9 months of diabetes. (A) Sample images of immunohistochemistry showing the expression
of TRPV1 in DRG neurons of wild-type and Ins2+/Akita mice (Akita). Arrows indicate neurons with
positive TRPV1 staining. (B) Percentage of TRPV1-positive neurons in wild-typ and Ins2+/Akita (Akita)
mice. Th perce tag of TRPV1-positiv neurons was determined in six segments of each mouse DRG
section and averaged. The dots represent the percentage determined for each wild-type or Ins2+/Akita
mouse (n = seven mice for each condition; p = 0.0008). (C) Sample traces of time-course of capsaicin
(Caps)-and 70 KCl-induced [Ca2+]i rises in DRG neurons isolated from one control or one Akita mouse.
The experiments were repeated five to six times in DRG neurons isolated from additional five to six
mice. Solid lines are av raged [Ca2+]i changes. The vertical lin s r present SEM. The compounds
were appli d at the times indicated with the horizon al bars. The rig t inset shows the summary of
fluorescence changes induced by 70 KCl. Each dot represents the averaged fluorescence change value
determined during a fluorescence imaging experiment on a coverslip with 20 to 150 DRG neurons
(n = 321–335 cells from five to six mice for each condition; p = 0.62). (D) The summary data of the
average percentage of DRG neurons sensitive to capsaicin. Each dot represents the averaged percentage
value determined in the tested c lls from each mous ( = five mice; p = 0.47). (E) Summary data of
the areas under the response curves for C. Each dot represents th averaged area values determined
for the tested cells on each coverslip. There were 20 to 150 isolated DRG neurons per coverslip from
one mouse assessed in each experiment. Five wild-type and six Ins2+/Akita mice were used for these
experiments. Only the neurons exhibiting Ca2+ increases in the presence of 70 KCl were included in
the statistics. The t test was used to determine whether there was a significant difference between the
tested groups (p = 0.027). * indicates p < 0.05 and *** indicates p < 0.001.
2.4. Voltage-Gated Calcium and TRPV1 Currents in Wild-Type and Ins2+/Akita DRG Neurons
Ion channels, such as voltage-gated potassium channels, re known to be altered i neurons
derived from diabetic rodents [2 ]. To determine the degree to which voltage-gated Ca2+ channels
were affected by a diabetic environment, we measured voltage-gated Ca2+ currents in small-and
mid-sized Ins2+/Akita and wild-type DRG neurons. The cells were cultured overnight before the whole
cell patch-clamp experiments. We found that the voltage-gated Ca2+ current amplitudes were not
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different in Ins2+/Akita (−157.9 ± 23.4 pA/pF, n = 15) and wild-type (−147.7 ± 21.1 pA/pF, n = 15,
Figure 2A,B) groups. This was in accordance with our Ca2+-imaging experiments where 70 KCl induced
similar calcium changes in Ins2+/Akita and wild-type neurons (Figure 1C, inset). We next assessed the
function of TRPV1 using capsaicin (2 µM) applications. Figure 2C,D illustrate that the average peak
TRPV1 current amplitudes were not significantly different in Ins2+/Akita neurons (−103.0 ± 24.8 pA/pF,
n = 7) and wild-type neurons (−67.8 ± 17.5 pA/pF, n = 7). However, the TRPV1 currents decayed
faster after reaching the peak value in Ins2+/Akita neurons than wild-type (Figure 2C insets). To evaluate
the current decay, the areas under the curve of capsaicin-induced currents were calculated. Figure 2E
shows that the Ins2+/Akita neurons had significantly smaller areas under the curve during capsaicin
application (63.0 ± 15.5, n = 7) than wild-type neurons (126.1 ± 22.3, n = 7). Although Ins2+/Akita and
wild-type neurons had similar capsaicin-induced peak currents, the currents decayed much faster
(Figure 2F, time constant: 91.5 ± 10.3 s vs 32.9 ± 8.1 s, respectively).
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increases and ROS production in wild-type DRG neurons to ascertain whether there is a correlation 
between the elevated glucose, ROS, and TRPV1 function. Isolated DRG neurons from wild-type 
C57BL/6J mice were treated with 25 mM glucose (25HG) for 7 days to mimic the diabetic 
environment. The percentage of cultured DRG neurons sensitive to capsaicin (100 nM) in the 25HG 
treated group was not different from that observed in the control group. The DRG neurons treated 
Figure 2. Voltage-gated calcium and TRPV1 currents in DRG neurons from wild-type and Ins2+/Akita
mice. (A) Sample traces of current-voltage relationships acquired during the voltage ramps from
−100 mV to +80 mV in wild-type (left) and Ins2+/Akita (Akita) DRG (right) neurons. The insets show
the voltage-gated calcium currents activated by depolarizing pulses to 0 mV. (B) The sum ary data of
the current densities recor e in wild-ty e nd Ins2+/Akita (Akita) DRG neurons (p = 0.75). (C) Sample
current traces obtained during the a plicati ns of 2 µM capsaicin (Caps) in wild-type Ins2+/Akita
(Akita) DRG neurons at a holding potential of −60 mV. The insets showed the fitted curves. A standard
exponential function was used to fit to the current decay (red curve). (D) The summary data of capsaicin
(Caps)-induced current densities for C (p = 0.27). (E) A comparison of the areas under the curves in
the presence of capsaicin (Caps) in wild-type and Ins2+/Akita (Akita) DRG neurons (p = 0.036). (F) The
summary data of th current decay tau values from wild-type and Ins2+/Akita DRGs. The t test was
used to determine whether there was a significant difference between the tested groups (p = 0.002). *
indicates p < 0.05.
2.5. High Glucose Decreased the Capsaicin-Evoked [Ca2+]i-Responses and Increased Intracellular
ROS Accumulation
We next investigated the effect of treatment with 25 mM glucose on capsaicin-induced [Ca2+]i
increases and ROS production in wild-type DRG neurons to ascertain whether there is a correlation
between the elevated glucose, ROS, and TRPV1 function. Isolated DRG neurons from wild-type
C57BL/6J mice were treated with 25 mM glucose (25HG) for 7 days to mimic the diabetic environment.
The percentage of cultured DRG neurons sensitive to capsaicin (100 nM) in the 25HG treated group
was not different from that observed in the control group. The DRG neurons treated with 25HG
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had significantly smaller intracellular calcium increases evoked by 100 nM capsaicin than control
neurons treated with only 5.5 mM glucose (Figure 3A,B, ∆F340/F380*s = 0.36 ± 0.19 vs ∆F340/F380*s
= 1.27 ± 0.26, respectively). Notably, the 15 mM KCl-induced [Ca2+]i responses were smaller in
DRG neurons treated with 25 mM glucose compared to control DRG neurons (Figure 3A, inset).
The cytoplasmic redox state was monitored using a ROS sensitive dye, 2′,7′-dichlorodihydrofluorescein
diacetate (DCFH-DA) [23,24], in cultured neurons under control and 25HG conditions. The DCFH-DA
fluorescence intensity in DRG neurons from 25HG-treated group was significantly increased as
compared to that in the control group (Figure 3C,D, 25HG: 0.83 ± 0.01, n = 585; control: 0.66 ± 0.01,
n = 765). These data suggest that the functional change of TRPV1 in short-term diabetic conditions
correlates with the increased levels of cytoplasmic ROS.
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Figure 3. Effect of high glucose treatment on capsaicin (Caps)-induced [Ca2+]i rises and intracellular
reactive oxygen species (ROS) accumulation in primary cultured DRG neurons. (A) Sample traces of
time-course of [Ca2+]i changes in cultured DRG neurons isolated from one mouse (n = 91 neurons for
control and n = 82 neurons for 25 HG). DRG neurons were tre t d with 5.5 mM (control, black) and 25 mM
glucose (25 HG, red) for 7 days. Solid and broken lines are averaged [Ca2+]i changes. The vertical lines
represent SEM. The compounds were applied at the times indicated with the horizontal bars. The inset
shows a comparison of 15 KCl-induced [Ca2+]i changes at the peak of the response in the control and
25HG groups. The data were averaged over five data points (n = 91 neurons for control and n = 82
neurons for 25HG; Mann–Whitney Rank Sum Test, p ≤ 0.001). (B) Summary data of the areas under
the capsaicin-induced [Ca2+]i response curves (sample curves are shown in A). The dots represent the
averaged area under the curves determined for each mouse. There were 20 to 150 isolated DRG neurons
per coverslip from one mouse assessed in each experiment. The experiments were repeated four times
(n = four mice). The t test was used to determine whether there was a significant difference between the
tested groups (p = 0.029). (C) The representative images of ROS detection by DCFH in DRG neurons
treated with 5.5 mM (control) or 25 mM glucose (25HG) for 7 days. (D) Sum ary of data shown in C.
ROS production was assessed in high glucose-treated DRG neurons (25HG) and control DRG neurons by
measuring the DCFH fluorescence intensity. The dots represent the averaged values of DCFH fluorescence
intensities calculated for each mouse. There were 77 to 256 isolated DRG neurons per coverslip from one
mouse assessed in each experiment. The experiments were repeated four times (n = four mice). The t test
was used to determine whether there was a significant difference between the tested groups (p = 0.017).
* indicates p < 0.05; *** indicates p < 0.001.
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3. Discussion
The major novel finding in this study is the fact that capsaicin-induced currents exhibit a markedly
accelerated rate of decay in Ins2+/Akita DRG neurons at 9 months of diabetes compared to DRG neurons
isolated from control DRGs. In addition, our data show that the TRPV1 expression is increased in
end-stage diabetes. However, the capsaicin-induced calcium responses are decreased, suggesting
the impaired TRPV1 function in diabetic DRG neurons. Consistent with previous reports [25,26],
we observed an increased production of ROS in DRG neurons cultured in the presence of 25 mM
of glucose, simulating a hyperglycemic state. The electrophysiological recordings do not show
impairment in the function of voltage-gated Ca2+ channels in Ins2+/Akita DRG neurons compared
to control DRG neurons.
Several studies, using streptozotocin (STZ)-treated mice, a model of type 1 diabetes, reported that
in DRG neurons, elevated TRPV1 expression is associated with hyperalgesia and decreased TRPV1
expression is linked to loss of pain sensation (hypoalgesia) [13,27]. There are several mechanisms
underlying the hyperalgesic phenotype in short-term diabetes, involving long non-coding RNA
BC168687 [28] and protein kinase C (PKC) activation [29]. However, it remains unclear how TRPV1
function and expression are modulated in hypoalgesia associated with end-stage diabetes.
Our data suggest that the percentage of TRPV1-positive neurons is increased in intact DRGs from
9-month diabetic Ins2+/Akita mice as determined by immunohistochemistry, whereas in cultured DRG
neurons, isolated from the same animals, the percentage of capsaicin-sensitive neurons is not different
between the diabetic and control groups as ascertained using the calcium imaging assay (Figure 1).
Moreover, we demonstrate that the percentage of capsaicin-sensitive neurons is higher in the primary
cultures than expected from the immunohistochemistry data. This apparent discrepancy may result
from several factors. Firstly, survival of certain populations of neurons may be variably affected during
the DRG dissociation procedure and short-term culture. Secondly, the TRPV1 protein is known to
be expressed on both the plasma membrane and the endoplasmic reticulum in sensory neurons [30],
whereas the calcium imaging assay evaluates TRPV1 function only in the plasma membrane at
nanomolar concentrations of capsaicin. The degree to which the observed protein changes affect
mechanical and thermal nociception is unknown. However, it was reported that 5-month diabetic
Ins2+/Akita mice already presented with impaired mechanical and thermal nociception [21]. This is
consistent with our calcium imaging and electrophysiology data revealing that TRPV1 activity decays
much faster in Ins2+/Akita DRG neurons at 9 months of diabetes.
A recent study reported a RAGE (receptor for Advanced Glycation End-products)-dependent
potentiation of TRPV1 currents in sensory neurons exposed to high glucose, implicating RAGE in
modulating TRPV1 [25], with high glucose treated DRG neurons showing potentiated capsaicin-evoked
TRPV1 currents and elevated intracellular ROS accumulation [25]. In our study, high glucose treatment
of DRG neurons also resulted in an increase in ROS production (Figure 3C). However, we observed
reduced capsaicin-stimulated responses in high glucose treated DRG neurons. We also did not observe
the potentiated peak amplitudes of capsaicin-induced currents in Ins2+/Akita DRG neurons at 9 months
of diabetes compared to control DRG neurons (Figure 2C–E), and we found that the currents exhibited
much faster decays (Figure 2F). Consistently, smaller capsaicin-induced intracellular calcium changes
were observed in Ins2+/Akita DRG neurons compared to wild-type neurons (Figure 1C,E). In the
previously cited study, data was obtained from neonatal or 2 to 3-month-old mice, while we used
>9 month-old mice. Therefore, we cannot exclude that our differing observations may be due to
animal age. Moreover, ligands that can accompany diabetic conditions and activate RAGE, such as
the inflammatory cytokine high-mobility group box-protein 1 (HMGB1, also known as amphoterin)
and methylglyoxal, may contribute to pain behavior in diabetic neuropathy via TRPV1 or transient
receptor potential ankyrin 1 (TRPA1)-dependent mechanisms [31,32].
The observed facilitated decay of TRPV1 activity reported in this study may be due to accelerated
desensitization of the channel. The mechanisms of the TRPV1 desensitization are diverse and may
involve multiple intracellular signaling pathways, and the process is often Ca2+-dependent [33].
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Notably, long capsaicin exposure induced TRPV1 endocytosis and degradation and decrease in
TRPV1 activity [34]. It is well known that phosphorylation of TRPV1 sensitizes the channel [35].
Consistently, dephosphorylation of p-TRPV1 by the phosphatase calcineurin was shown to lead to
TRPV1 desensitization [36]. Several other mechanisms of TRPV1 desensitization were also proposed
such as binding of calmodulin [37] and the depletion of phosphatidylinositol 4,5-diphosphate from
the plasma membrane [38]. Future experiments will be needed to establish whether these processes
modulate TRPV1 activity in the setting of end-stage diabetes.
Chuang and Lin reported that H2O2 activates TRPV1 and potentiates the capsaicin-induced
TRPV1 currents [15], whereas DelloStritto et al. (2016, [16]) demonstrated that the prolonged treatment
with H2O2 reduced the capsaicin-induced TRPV1 current amplitude in HEK cells. Thus, ROS might
modulate TRPV1 activity. The mechanism for H2O2-dependent modulation of TRPV1 function remains
to be determined. Ca2+ influx through TRPV1 may facilitate Ca2+-dependent desensitization of
the channel [39], signifying that H2O2 may be a possible factor in the inhibitory effect of diabetic
environment on TRPV1 through a Ca2+ dependent mechanism. Alternatively, Chuang and Lin (2009)
reported [15] that marked H2O2-dependent sensitization of TRPV1 might be due to the formation of
disulfide bonds, likely between the N-terminal C158 and the C-terminal C783. Further experiments will
be needed to determine whether Ca2+ influx or H2O2–dependent specific cysteine residue oxidation
and reversible disulfide bond formation [40] underlies the accelerated TRPV1 current decay observed in
Akita DRG neurons at 9 months of diabetes. Long-term in vivo treatment with antioxidants in diabetic
Akita mice will be needed to provide evidence whether an association exists between long-term ROS
accumulation and the accelerated kinetics of TRPV1 current decay observed in end-stage diabetes.
A subset of TRPV1-positive DRG neurons co-expresses the TRPA1 channel. It has been
reported that TRPA1 and TRPV1 channels can interact physically and functionally [41–43]. Notably,
heterologous desensitization between these two channels may occur in DRG neurons [41]. Since H2O2
also activates TRPA1 [44], it is possible that ROS-dependent activation of TRPA1 channels followed
by heterologous TRPV1 desensitization may lead to accelerating the TRPV1 current decay rate.
On the other hand, a recent study [43] provided evidence that in TRPA1-positive DRG neurons,
the decay rate of capsaicin-induced currents was apparently slower due to cross-activation of
TRPA1 by capsaicin-induced calcium influx, suggesting that TRPA1 protein depletion may result
in accelerating the decay rate of capsaicin-induced currents. Thus, it remains to be determined whether
cross-desensitization or cross-activation between TRPA1 and TRPV1 would prevail in regulating
TRPV1 current kinetics in diabetes.
In addition to being activated by low pH and capsaicin, TRPV1 is also activated by heat.
A recent study [21] found reduced behavioral sensitivity to noxious heat associated with a reduced
temperature-activated [Ca2+]i-response amplitude in DRG neurons from Ins2+/Akita mice at 20 weeks of
diabetes. However, the authors reported that no difference was observed in capsaicin-evoked [Ca2+]i
responses in wild-type and Ins2+/Akita DRG neurons. We found decreased overall capsaicin-induced
[Ca2+]i increases in diabetic Ins2+/Akita DRG neurons compared to wild-type DRG neurons. This may
be because our Ins2+/Akita diabetic mice had 9 months of diabetes, which is more comparable to
end-stage diabetes.
In summary, we found that long-term diabetic Ins2+/Akita DRG neurons exhibited decreased
capsaicin-induced Ca2+ transients that decayed faster. High glucose-treated DRG neurons produced
increased amounts of ROS. Although ROS is known to modulate TRPV1 function [15,45], it remains
unclear whether ROS accumulation in Akita mice directly or indirectly results in TRPV1 function
impairment. We propose that the accelerated decay rate of capsaicin-induced TRPV1 activity (Figure 4)
may contribute to reduced pain sensation in end-stage diabetes.
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Figure 4. Diagra shows the putative changes in TRPV1 functional activity in DRG neurons. The upper
panel shows a healthy DRG neuron and the lower panel shows a DRG neuron in late-stage diabetes.
Sample capsaicin-activated TRPV1 current traces are demonstrated for each condition. High glucose
induces increased ROS production in DRG neurons. Accelerated current decay is a characteristic
feature of capsaicin-activated TRPV1 currents in DRG neurons isolated from Akita mice at 9 months
of diabetes.
4. aterials and ethods
4.1. Animals
All animal procedures were performed in accordance to the National Institutes of Health (NIH)
guide and were approved by the Indiana University School of Medicine Institutional Animal Care and
Use Committee (Animal Protocol #11165). Mice were euthanized using isoflurane anesthesia followed
by decapitation. C57BL/6J wild-type and Ins2+/Akita mice were obtained from The Jackson Laboratory
(Bar Harbor, ME, USA) and bred in the animal facilities at the Indiana University School of Medicine.
4.2. Dorsal Root Ganglia (DRG) Neuron Isolation
DRG neurons were isolated f m c n r l C57BL/6J wild-type or Ins2+/Akita mice using methods
described previously [46]. Briefly, thoracic and lumbar (T1-L5) DRGs were collected and placed into
cold Phosphate Buffered Saline (PBS) containing no Ca2+ or Mg2+. DRGs were digested in collagenase
P (1 mg/mL, from Clostridium histolyticum, Roche, Indianapolis, IN, USA) solution in Hank’s
Balanced Salt medium supplemented with 0.2 mM CaCl2, 0.12% bovine serum albumin (BSA), and
the Trypsin Inhibitor from soybean (0.1 mg/mL, Roche, Indianapolis, IN, USA) for 30 to 60 min.
DRG neurons were dispersed by trituration and then plated onto Growth Factor Reduced Matrigel
(Life Technologies, Grand Island, NY, USA)-coated 15 mm glass coverslips and cultured for 24 h in
Minimum Essential Medium (Life Technologies) supplemented with 0.2% BSA, 100 U/mL penicillin,
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100 µg/mL streptomycin, and 20 ng/mL NGF-2.5S (BD Biosciences, Bedford, MA, USA) at 37 ◦C in a
water-jacketed 5% CO2 incubator.
4.3. Whole-Cell Patch-Clamp Recordings
The capsaicin-activated TRPV1 currents were recorded from DRGs using an Axopatch 200B
amplifier (Molecular Devices, San Jose, CA, USA) as indicated elsewhere [46–50]. Briefly, the analog data
were digitized using an analog-digital converter Digidata 1440a at a sampling rate of 1 kHz. The currents
were filtered at 3 kHz. Series resistance compensation was set to 50%. The external solution contained
(in mM): 145 NaCl, 2.5 KCl, 1.2 CaCl2, 1 MgCl2, 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES), and 5.5 glucose (pH 7.2). The intracellular solution contained the following (in mM):
125 CsMeSO3, 3.77 CaCl2, 2 MgCl2, 10 EGTA (100 nM free Ca2+), and 10 HEPES (pH 7.2). For TRPV1
current or voltage-gated calcium current recording in DRG neurons, 3 mM ATP-Mg was added into the
intracellular solution. An episodic stimulation voltage protocol was used to record TRPV1 currents.
Cells were voltage-clamped at a potential of −60 mV and voltage ramps from −100 to +100 mV
were applied at 2-s intervals. The voltage protocol for voltage-gated calcium current was as follows:
Cells were voltage-clamped at a holding potential of −80 mV, a 20 ms depolarizing pulse to 0 mV was
used to transiently activate the voltage-gated calcium channels, and then a voltage ramps from −100
to +80 mV was applied. The voltage protocol was repeated with an interval of 15 s throughout the
experiment. During the voltage-gated calcium current recordings, Ba2+ was used as a surrogate for Ca2+.
The Ba2+ extracellular solution contained (in mM): 135 N-methyl-D-glucamine (NMDG)-Cl, 10 BaCl2,
10 HEPES, and 5.5 glucose (pH 7.2). The pCLAMP 10 software package (Molecular Devices, San Jose,
CA, USA) was used for acquisition control and data analyses. The current density was calculated by
dividing the peak current by the cell capacitance. The data was obtained from 7 to 15 DRG neurons
from 4 to 6 mice in each group. Data were fitted to a single exponential function. All of the experiments
were performed at room temperature (22 to 25 ◦C).
4.4. Intracellular [Ca2+]i Measurements
Fluorescence imaging experiments were performed as described previously [46,51]. Briefly,
DRG neurons were loaded with Fura-2AM (4 µM) in Ca/Mg-PBS for one hour followed by an
additional 30-minute incubation in Ca/Mg-PBS without Fura-2AM. A Till Photonics single-cell
fluorescence imaging system was used to monitor intracellular Ca2+ changes in single Fura-2-loaded
DRG neuron. The standard extracellular solution contained (in mM): 145 NaCl, 2.5 KCl, 1.2 CaCl2,
1 MgCl2, 10 HEPES, and 5.5 glucose (pH 7.2). 70 mM KCl (70 KCl) solution contained (in mM):
77.5 NaCl, 70 KCl, 1.2 CaCl2, 1 MgCl2, 10 HEPES, and 5.5 glucose (pH 7.2). The 15 mM KCl (15KCl)
was obtained by mixing the standard extracellular solution and 70 KCl solution at a ratio of 11/2.5.
The cells were superfused continuously with the test solutions at a rate of 1.5 mL/min. DRG neurons
were identified by their appearance (round cells with processes). Only DRG neurons responding with
pronounced Ca2+ influx upon KCl-induced depolarization were used for analyses. There were 3 to
6 mice used in each experimental group (20 to 150 isolated DRG neurons from one mouse in each
single experiment).
4.5. ROS Measurements
To measure cytoplasmic ROS levels, we used OxiSelectTM Intracellular ROS Assay Kit
(Green Fluorescence; Cell Biolabs, San Diego, CA, USA). DRG neurons from C57BL/6J mice were
cultured in either control or high glucose for 7 days. For high glucose solution, the concentration of
glucose was increased to 25 mM. Following this, the neurons were incubated for one hour at 37 ◦C
with medium containing DCFH-DA (1 mM) and subsequently washed three times with PBS. A Till
Photonics single-cell fluorescence imaging system was used to take the florescent images of neurons at
room temperature. For each image, we defined regions of interest and measured the mean fluorescent
intensity. The background-subtracted fluorescence intensity values were compared in control and
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high glucose DRG neurons to determine the ROS level increases under high glucose condition in
DRG neurons.
4.6. Immunocytochemistry
Isolated DRGs were fixed in 10% neutral formalin and embedded in paraffin blocks and sectioned
at 5 microns. Deparaffinized sections of the ganglia were incubated with the primary goat TRPV1
antibody in dilution buffer (3% normal horse serum and 0.04 Triton-x; Santa Cruz, Cat. # sc-398417;
dilution factor: 1:100) overnight at 4 ◦C followed by three washes in PBS. The sections were then
incubated with the secondary antibody (dilution factor: 1:1000, Donkey-anti-goat biotin-conjugated
antibody, Sigma-Aldrich, St. Louis, MO, USA). After the secondary antibody was removed by multiple
PBS washes, the sections were treated with horseradish peroxidase-conjugated streptavidin. The color
was developed using diaminobenzidine. DRG sections (6 sections from each mouse) were randomly
selected from wild-type (n = 7) or Ins2+/Akita (n = 7) mice and TRPV1-expressing neurons were counted
by blinded assayer using Image-Pro Premier 9.3 (Media Cybernetics, Rockville, MD, USA).
4.7. Chemicals
All inorganic salts and buffers were purchased from Sigma (St. Louis, MO, USA). The TRPV1
antibody was from Santa Cruz (Cat. # sc-398417, Dallas, TX, USA). Fura-2AM (Cat. # F-1221) was from
Thermo Fisher Scientific (Waltham, MA, USA).
4.8. Statistical Analysis
The SigmaPlot 12 software (Systat software, San Jose, CA, USA) was used to perform the statistical
analyses. The unpaired t test was used to determine the significant difference between two groups
of data with normally distributed populations and equal variances, whereas the Mann–Whitney
Rank Sum Test was used to determine the significant difference between two groups of data with
non-normally distributed populations and different variances. The significance level was set to <0.05.
All data were presented as mean ± standard error of the mean (SEM).
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